...
首页> 外文期刊>Disease markers >The Role, Function, and Mechanism of Long Intergenic Noncoding RNA1184 (linc01184) in Colorectal Cancer
【24h】

The Role, Function, and Mechanism of Long Intergenic Noncoding RNA1184 (linc01184) in Colorectal Cancer

机译:长期非癌症癌症中长性非癌症NN1184(LINC01184)在结肠直肠癌中的作用,功能和机制

获取原文
           

摘要

Background . Long intergenic noncoding RNA1184 (linc01184) has been recently discovered; however, its role in human diseases is limited to date. The present study is aimed at investigating the expression pattern and mechanism of linc01184 in colorectal cancer (CRC) tumorigenesis. Methods . The expression of linc01184 in CRC tissues and cell lines was compared with that in normal controls. The functions of linc01184 in CRC cells were identified by overexpression and small interfering RNA (siRNA) approaches in vitro. Meanwhile, the target gene prediction software, luciferase reporter, RNA pull-down, and western blotting assays were used to analyze the oncogenic mechanism. Results . We found that linc01184 was obviously upregulated in CRC tissues and cells when compared to normal controls, and its upregulation had a positive association with the CRC progression. linc01184 knockdown significantly suppressed CRC cell proliferation and invasion and promoted apoptosis. Besides, linc01184 acted as a competitive endogenous RNA (ceRNA) by directly binding to microRNA-331 (miR-331), and its overexpression resulted in notable increases of human epidermal growth factor receptor 2 (HER2), phosphorylated Ser/Thr kinases (p-Akt), and extracellular regulated protein kinase 1/2 (p-ERK1/2) at posttranscriptional levels in CRC cells, which were antagonized by miR-331. Conclusions . The findings reveal for the first time that linc01184 is an enhancer for the proliferation and invasion of CRC by functioning as a ceRNA through the linc01184-miR-331-HER2-p-Akt/ERK1/2 pathway regulatory network.
机译:背景 。最近已经发现了长期的非依赖性非编码RNA1184(LINC01184);然而,其在人类疾病中的作用仅限于日期。本研究旨在调查LINC01184在结肠直肠癌(CRC)肿瘤发生中的表达模式和机制。方法 。将LINC01184在CRC组织和细胞系中的表达与正常对照进行比较。通过体外过表达和小干扰RNA(siRNA)鉴定CRC细胞中LINC01184的功能。同时,使用靶基因预测软件,荧光素酶报告,RNA下拉和蛋白质印迹测定来分析致癌机制。结果 。与正常对照相比,我们发现LINC01184在CRC组织和细胞中显然是上调,其上调与CRC进展具有阳性关系。 LINC01184敲低显着抑制了CRC细胞增殖和侵袭和促进凋亡。此外,LINC01184通过直接结合MicroRNA-331(miR-331),作为竞争内源性RNA(Cerna),其过表达导致人表皮生长因子受体2(HER2),磷酸化的Ser / Thr激酶(P -akt)和细胞外调节蛋白激酶1/2(p-ERK1 / 2)在CRC细胞的后颅面术水平,由miR-331拮抗。结论。该研究结果表明,LINC01184是通过用LINC01184-MIR-331-HER2-P-AKT / ERK1 / 2路径调节网络发挥为CERNA的增殖和侵入CRC的增强剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号